Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 20;19(1):423-430.
doi: 10.1007/s40200-020-00494-4. eCollection 2020 Jun.

Adjusted tight control blood glucose management in diabetic patients undergoing on pump coronary artery bypass graft. A randomized clinical trial

Fatemeh Javaherforoosh Zadeh  1 , Simin Azemati  2
Affiliations

Adjusted tight control blood glucose management in diabetic patients undergoing on pump coronary artery bypass graft. A randomized clinical trial

Fatemeh Javaherforoosh Zadeh et al. J Diabetes Metab Disord. .

Erratum in

Abstract

Background: Many of the patients who are undergoing Coronary Artery Bypass Graft have diabetes mellitus or metabolic syndrome and are at risk for hyperglycemia events.

Objective: The present study aimed to compare conventional glucose control with adjusted tight control in patients undergoing on-pump CABG.

Methods: This double -blind randomized clinical trial study was conducted in Shiraz, Iran, from September 2017-March 2018. Two consecutive groups of 75 patients undergoing elective on- pump coronary artery bypass graft surgery.

Intervention: The patients were divided into adjusted tight control of the blood glucose between 100 and 120 mg/dl and conventional method that the blood glucose maintained ≤200 mg/dl.

Primary outcomes were: mortality, sternal wound infection, cardiac arrhythmia, cerebrovascular attack, and acute renal failure.

Secondary outcomes included: duration of mechanical ventilation and length of ICU staying. The same main outcomes were evaluated after one month.

Statistical analysis: The data were analyzed using SPSS version 20(SPSS, Chicago, IL). Group comparisons were performed using t-tests and Chi-square tests. Repeated measurement test was used for comparing blood glucose in two groups. Mann Whitney U test was compared duration of the mechanical ventilation and length of ICU staying. Statistical significance was defined as a p value <0.05.

Results: There were no significant differences between main and secondary outcomes. About late outcomes, sternal wound infection was in the control group (7 patients) more than intervention (1 patient) (P < 0.05). No differences between other complications in both groups were observed. The occurrence of hypoglycemia was low in both groups. Hypokalemia was significantly higher in the intervention than in control (P < 0.001).

Conclusions: The findings showed using adjusted tight glycemic control to a level that is nearby to normal values during cardiac surgery may reduce episodes of hypoglycemia and thus reduces its side effects. As well as reduce hyperglycemic complications such as sternal wound infection.

Trial registration number: IRCT2013041713052N1). 2013-07-09.

Keywords: Cardiac surgery; Critically ill patient; Diabetes; Tight control of glucose.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.Conflicting interestThere is no conflict of interest to be declared.

Figures

Fig. 1
Fig. 1
Flow chart of study inclusion criteria
Fig. 2
Fig. 2
Comparison of trend of changes in the mean ± SD of the blood glucose levels in patients during surgery between two groups. * mean significant differences (P < 0.001)
Fig. 3
Fig. 3
Comparison of trend of changes in the mean ± SD of the blood glucose levels in patients in ICU between two groups.* mean significant differences (P < 0.001)
See this image and copyright information in PMC

References

    1. Gorter PM, Olijhoek JK, van der Graaf Y, Algra A, Rabelink TJ, Visseren FL, et al. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis. 2004;173(2):361–367. doi: 10.1016/j.atherosclerosis.2003.12.033. - DOI - PubMed
    1. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002;40(3):418–423. doi: 10.1016/S0735-1097(02)01969-1. - DOI - PubMed
    1. Raza S, Blackstone EH, Sabik JF., III The diabetes epidemic and its effect on cardiac surgery practice. J Thorac Cardiovasc Surg. 2015;150(4):783. doi: 10.1016/j.jtcvs.2015.07.037. - DOI - PMC - PubMed
    1. Booya F, Bandarian F, Larijani B, Pajouhi M, Nooraei M, Lotfi J. Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol. 2005;5(1):24. doi: 10.1186/1471-2377-5-24. - DOI - PMC - PubMed
    1. Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. The Journal of thoracic and cardiovascular surgery. 2005;130(4):e1–e8. doi: 10.1016/j.jtcvs.2005.05.049. - DOI - PubMed